Health
India’s drugs regulator rejects Bharat Biotech’s request for COVID-19 vaccine trials on children – Xinhua | English.news.cn – Xinhua
NEW DELHI, Feb. 25 (Xinhua) — India’s drugs controller has rejected vaccine maker Bharat Biotech’s request to conduct clinical trials of Covaxin on children and asked the company to submit its report on the efficacy of the COVID-19 vaccine, local media said Thursday.
The drugs regulator’s rejection came after hearing an application by Hyderabad-based pharma company on Wednesday sought approval for Phase 3 clinical trials of Covaxin on children between 5-18 years of age.
The subject expert committee…
-
General23 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News20 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News22 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General16 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank